Filter results:

News about future improvements to the fund and tips for writing strong applications.

Mike Turner

News | 22 January 2019

Acting Director of Science announced

Mike Turner has been appointed Acting Director of Science at Wellcome.

Developing new vaccines is challenging, costly and complex. CEPI is a new model for funding vaccine development which aims to change this.

Alyson Fox, our Director of Grants, explains why we’re changing our policy on transferring grants to ensure research can thrive in the UK, EU and beyond.

Director of Innovation Stephen Caddick explains how his team has built its global portfolio to around £1 billion, touching the lives of more than 1.8 million people.

Jeremy Farrar, Wellcome's Director, and Mike Ferguson, Deputy Chair of our Board of Governors, have both been knighted in the New Year's Honours 2019

During 2018 we've featured stories about trailblazing research by people we support. Here are some highlights.

At $60 billion a year, epidemics cost far more than putting in place the systems to prepare for them.

Our investments portfolio grew to almost £25.9 billion by 30 September 2018, strengthening our ambition to spend more than £5 billion over five years on charitable activities.

If we put research at the heart of epidemic response, it’s a double win – helping fight outbreaks that are underway and protecting us in the future.

Pages